EQS Group-Ad-hoc: Evolva Holding SA / Key word(s): Miscellaneous Reinach, March 16, 2021 - Evolva (SIX:EVE), has published today the agenda for its Annual General Meeting to be held on April 8, 2021. Physical attendance by shareholders is not permitted. Shareholders may cast their votes by the authorized independent proxy (please consult the invitation for further information). With the necessary commercial building blocks in place following the US approval of nootkatone in August 2020, the launch of L-arabinose, and customer demand rising in Health Ingredients (order intake: +71% compared to 2019), the company is now fully focused on further strengthening manufacturing and supply chain. Increase of Authorized Capital Elections of the Chairman and of the Board of Directors Christoph Breucker is proposed as new candidate. Elections to the Compensation Committee Election of the Auditors Documents for the AGM, including the information notice with a full agenda and the proposals of the Board of directors, are available online at evolva.com/shareholder-info/annual-general-meeting-of-shareholders/. Update Convertible Loan with Nice & Green SA About Evolva For Evolva multimedia content, please visit: evolva.com/multimedia-library. Disclaimer For Evolva multimedia content, please visit: evolva.com/multimedia-library. Contact End of ad hoc announcement |
Language: | English |
Company: | Evolva Holding SA |
Duggingerstrasse 23 | |
4153 Reinach | |
Switzerland | |
Phone: | +41 61 485 20 00 |
Internet: | www.evolva.com |
ISIN: | CH0021218067 |
Valor: | 2121806 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1175827 |
End of Announcement | EQS Group News Service |
|
1175827 16-March-2021 CET/CEST